Identifying natural substances that regulate microRNAs (miRNAs) has facilitated the development of innovative therapeutic strategies for brain cancer therapy. This work investigates the intricate interaction between miRNA expression and the specified chemicals, aiming to comprehend how natural compounds may modify miRNA profiles to affect carcinogenic pathways. Curcumin and resveratrol are natural compounds that have lately shown anticancer effects. These drugs function by modifying the expression of certain miRNAs linked to tumor proliferation and treatment resistance. Natural therapies can target these miRNAs, potentially improving therapy effectiveness and mitigating the adverse effects often linked to conventional pharmaceuticals. This review collects the latest findings on the impact of natural compounds on miRNAs. It presents an innovative approach to brain cancer treatment by leveraging the bioactivity of these substances to reinstate normal miRNA function. Natural chemicals provide a comprehensive strategy for addressing brain cancer, underscoring their significance in transforming future therapeutics. From this perspective, natural compounds provide a means to combat brain cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00210-025-03934-1 | DOI Listing |
Nat Prod Rep
March 2025
Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, 117543, Singapore.
Covering: up to early 2025Privileged compound classes of anti-inflammatory natural products are those where there are many reported members that possess anti-inflammatory properties. The identification of these classes is of particular relevance to drug discovery, as they could serve as valuable starting points in developing effective and safe anti-inflammatory agents. The privileged compound classes of natural products include the polyphenols, coumarins, labdane diterpenoids, sesquiterpene lactones, isoquinoline and indole alkaloids, each offering a variety of molecular scaffolds and functional groups that enable diverse interactions with biological targets.
View Article and Find Full Text PDFFront Pharmacol
February 2025
Department of Geriatrics, Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
Gastric cancer (GC) is a prevalent malignant tumor that originates from the epithelial cells of the gastric mucosa, predominantly in the form of adenocarcinoma. Extensive research has confirmed the significant role of autophagy in the initiation, progression, and chemoresistance of GC. The potential of traditional Chinese medicine (TCM) to exert anti-tumor effects by modulating autophagy has been demonstrated, particularly in the context of GC prevention and treatment.
View Article and Find Full Text PDFIran J Pharm Res
November 2024
Cancer Immunology and Immunotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Background: Chemotherapy remains a primary approach to cancer treatment, widely applied in bladder cancer (BC). However, the various side effects and resistance associated with chemotherapeutic drugs pose significant challenges in BC therapy, prompting interest in natural compounds like luteolin. Studies focus on its effects on key biological processes involved in BC, including metastasis, apoptosis, and autophagy.
View Article and Find Full Text PDFIran J Pharm Res
December 2024
Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background: Atherosclerosis remains the leading cause of mortality worldwide, highlighting the urgent need for innovative treatments targeting chronic inflammation. Recent research indicates that quercetin (QCT) and curcumin, two naturally occurring compounds, have potential therapeutic benefits in cardiovascular diseases.
Objectives: This study focuses on the novel synthesis of nano-quercetin (N-QCT) encapsulated in solid lipid nanoparticles (SLNs) and investigates the synergistic cardioprotective effects of N-QCT and curcumin on human vascular smooth muscle cells (VSMCs).
Iran J Pharm Res
December 2024
Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
Background: The receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 interacts with the angiotensin-converting enzyme 2 (ACE2) receptor in humans. To date, numerous SARS-CoV-2 variants, particularly those involving mutations in the RBD, have been identified. These variants exhibit differences in transmission, pathogenicity, diagnostics, and vaccine efficacy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!